AngioDynamics Stock News

AngioDynamics (ANGO) witnesses revenue growth across two business segments in fiscal Q2.

AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q2 2021 Results - Earnings Call Transcript

AngioDynamics (ANGO) delivered earnings and revenue surprises of 150.00% and 8.01%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology,

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology,

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology,

Assenagon Asset Management S.A. lifted its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 26.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchang

Declines in procedure counts have increased the pressures on AngioDynamics' business, but weak core growth is a long-standing issue, as is weak margin leverage.

AQR Capital Management LLC lifted its stake in AngioDynamics, Inc. (NASDAQ:ANGO) by 12.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Ex

De netto omzet van AngioDynamics steeg met 6,3% in Q1. Het bedrijf verwacht een jaarlijkse netto omzet van £215,97 tot £220,63 miljoen.

L'azienda si aspetta da £215,97 a £220,63 milioni di vendite nette annuali. AngioDynamics valuta la sua liquidità e gli equivalenti a £37,21 milioni.

AngioDynamics’ net sales jump 6.3% in the fiscal first quarter. The company expects £215.97 to £220.63 million of annual net sales.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular dise

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular dise

The global central venous catheter market will rise during the forecast period due to new product launches and product approvals.